Moderators of strength gains and hypertrophy in resistance training: A systematic review and meta-analysis.

This meta-analysis investigated the role of resistance training (RT) moderators on strength and muscle mass gains in untrained young (YG) and older (OG) adults. Electronic databases were searched for randomised controlled trials simultaneously assessing muscle strength and mass. Effect sizes (ES) reflecting improvements in strength and muscle mass were found for all moderators in YG and OG (ES 0.25- to 1.72;p < 0.05), excepting muscle mass in YG after RT was performed with <3 sets/exercise. Strength gains (p < 0.001) were greater in non-periodised vs. periodised RT in YG (ES 1.72 vs. 1.05) and OG (1.40 vs. 0.74). ES in OG was greater (p < 0.04) when RT included non-failure vs. failure repetitions (1.35 vs. 0.96), 3 vs. >3 sets/exercise (1.30 vs. 0.90), ≥3 vs. <3 days/week (1.70 vs. 0.78), and ≥12 vs. <12 weeks (1.48 vs. 0.92). Amoderating effect of RT factors on muscle mass was not detected in YG, while greater ES was found in OG for RT with ≥3 vs. <3 days/week (0.50 vs. 0.25). Concluding, different combinations of RT factors improved strength and muscle mass in YG and OG. In OG, this was favoured by greater frequency and duration, although hampered by excessive volume.

Resistance training to reduce resting blood pressure and increase muscle strength in users and non-users of anti-hypertensive medication: A meta-analysis.

Objective: The aim of this study was to conduct a systematic review with meta-analysis to analyze the effect of resistance training variables prescription on resting systolic (SBP) and diastolic blood pressure (DBP) and muscle strength changes. Methods: The search was conducted in the PubMed, Web of Science, and SPORTDiscus databases until August 2020 for randomized controlled trials with non-exercising control group. Results: In total, 36 studies qualified for inclusion in this meta-analysis. Eleven studies included users of antihypertensive medication, while the remaining 25 studies were conducted with non-users of antihypertensive medication. Resistance training only reduced SBP (-0.56 [-0.77 to -0.35]; P < .001) and DBP (-0.46 [-0.68 to -0.24]; P < .001) in anti-hypertensive medication users, with changes ranging from -6.1 to -2.8 mmHg for SBP and -4.6 to -1.6 mmHg for DBP. Muscle strength increased significantly in both users (0.76 [0.49 to 1.02]; P < .001) and non-users of antihypertensive medication (0.94 [0.71 to 1.16]; P < .001). Resistance training should be performed by users and non-users of antihypertensive medication for 8 to 16 weeks (2 to 3 days a week) and 8 to 12 non-failure repetitions. However, users should train with less load (60-80 vs 70-85% 1RM) and exercise sets (1-3 vs 2-4) than non-users of antihypertensive medication. Conclusion: Resistance training increases muscle strength and reduces resting SBP and DBP in individuals under BP pharmacological therapy, while in individuals who do not use antihypertensive drugs, resistance training only increases strength.